Amid questions raised by experts and opposition about the restricted-use approval given to Covaxin despite no efficacy data from phase III trials, Dr. Krishna Ella of Bharat Biotech said Monday that the The company had “tremendous experience” in vaccine development and the criticism against it was a “backlash.” against Indian …
Read More »‘Covaxin is 200% safe, doesn’t deserve a backlash’ – Bharat Biotech MD on efficacy issues
